Preclinical Study Reveals Potential of Multireceptor Antagonist to Block CGRP and PACAP
Neurology Live,
A multireceptor antagonist was developed to block CGRP and PACAP activity, potentially improving migraine treatment efficacy.
Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists
Overview of attention for article published in Headache: The Journal of Head & Face Pain, February 2025
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (90th percentile)
-
High Attention Score compared to outputs of the same age and source (80th percentile)
Readers on
- mendeley
- 11 Mendeley